Best In Depth Script Review Podcasts (2025)

1
Modular Flow Chemistry and the Future of Continuous Manufacturing 16:30

Play Pause

3d ago16:30

16:30

Flow chemistry and modular continuous platforms are gaining momentum as pharma searches for faster, more flexible, and more sustainable ways to develop and scale small-molecule processes. Yet questions around integration, scale-up, and regulatory expectations continue to influence how quickly these technologies can be fully adopted. In this episode…

1
The Economics Behind U.S. Generic Drug Manufacturing: Part Two 16:16

17d ago16:16

16:16

In this episode of Off Script, we continue our conversation with John Murphy III, president and CEO of the Association for Accessible Medicines, to dig deeper into the vulnerabilities and structural challenges shaping U.S. generic and biosimilar drug production. Murphy examines the most fragile links in the supply chain — from the lack of domestic …

1
The Economics Behind U.S. Generic Drug Manufacturing: Part One 16:22

22d ago16:22

16:22

In this episode of Off Script, we spoke with John Murphy III, president and CEO of the Association for Accessible Medicines, about the forces shaping the future of U.S. generic and biosimilar manufacturing. Murphy provides a high-level look at the pivotal shifts defining the generic drug landscape and breaks down the economic realities driving drug…

1
CGT Manufacturing Challenges and Opportunities 19:28

1M ago19:28

19:28

While the cell and gene therapy space represents one of the most exciting therapeutic frontiers in modern biopharma by offering highly personalized, transformative treatments, the sector still faces significant hurdles before it can achieve widespread commercialization. From steep manufacturing costs and a lack of standardization to persistent inef…

1
The State of CDMO Funding: 2025 in Review (Part Two) 17:17

1M ago17:17

17:17

In part two of our conversation with Brian Scanlan, Advisor of Life Sciences at Edgewater Capital Partners, we explore how today’s CDMO funding trends are shaping the next phase of growth and specialization across the contract research and manufacturing ecosystem. Brian shares his perspective on: The outlook for cell and gene therapies, where clini…

1
Halloween 41:27

1M ago41:27

41:27

Episode One: Halloween Join us for an in-depth discussion about John Carpenter and Debra Hill's script for Halloween. Host Luke Foster is joined by director and producer Sylvia Caminer, director, writer and producer Pat Higgins, writer/director Ethan Evans and writer/producer Jess Bartlett. Writer/Director Nathan Haines fields questions and comment…

1
The State of CDMO Funding: 2025 in Review (Part One) 22:03

1M ago22:03

22:03

As we near the end of 2025, the CDMO industry finds itself at a pivotal financial and strategic juncture — shaped by constrained funding, shifting demand, and renewed investor scrutiny. In this episode of Off Script, we speak with Brian Scanlan, Advisor of Life Sciences at Edgewater Capital Partners, to examine how the year’s market and investment …

1
The Play Podcast - 104 - Twelfth Night, by William Shakespeare 1:12:06

2M ago1:12:06

1:12:06

Episode 104: Twelfth Night by William Shakespeare Host: Douglas Schatz Guest: Will Tosh Welcome to The Play Podcast where we explore the greatest new and classic plays. Each episode we choose a single play to talk about in depth with our expert guest. We'll discuss the play's origins, its themes, characters, structure and impact. For us the play is…

1
Corporate compliance involves more than just cGMP and quality 16:51

2M ago16:51

16:51

This episode of Off Script: A Pharma Manufacturing Podcast features a conversation with Jana Falkenberg, senior legal counsel and corporate compliance officer at Vetter Pharma, a global contract development and manufacturing organization (CDMO) headquartered in Germany. Falkenberg, who is responsible for the continuous improvement of the compliance…

1
Charting Pharma Manufacturing Trends: Part Two 16:26

2M ago16:26

16:26

Building on insights from CRB’s Horizons: Life Sciences 2025 report, this second installment of our conversation with Peter Walters, Fellow of Advanced Therapies at CRB, explores the modalities driving forward momentum across the life sciences industry, the expanding role of standardization in manufacturing networks, and how tariffs and domestic in…

1
Charting Pharma Manufacturing Trends: Part One 13:16

2M ago13:16

13:16

By Pharma Manufacturing

1
The Play Podcast - 103 - Titus Andronicus, by William Shakespeare 57:51

2M ago57:51

57:51

Episode 103: Titus Andronicus by William Shakespeare Host: Douglas Schatz Guest: Max Webster Welcome to The Play Podcast where we explore the greatest new and classic plays. Each episode we choose a single play to talk about in depth with our expert guest. We'll discuss the play's origins, its themes, characters, structure and impact. For us the pl…

1
The Play Podcast - 102 - Every Brilliant Thing, by Duncan Macmillan and Jonny Donahoe 46:14

3M ago46:14

46:14

Episode 102: Every Brilliant Thing by Duncan Macmillan and Jonny Donahoe Host: Douglas Schatz Guests: Duncan Macmillan Jonny Donahoe Welcome to The Play Podcast where we explore the greatest new and classic plays. Each episode we choose a single play to talk about in depth with our expert guest. We'll discuss the play's origins, its themes, charact…

1
Editor’s (re)View: It matters if Big Pharma is fudging its US investment numbers 4:00

3M ago4:00

4:00

Large biopharma companies in recent months have pledged billions of dollars in capital expenditures for U.S. manufacturing and R&D facilities. What if it’s not accurate?Greg Slabodkin Read by Brittany Duncan https://www.pharmamanufacturing.com/editors-review/article/55314470/editors-review-it-matters-if-big-pharma-is-fudging-its-us-investment-numbe…

1
Can CDMOs keep up with the increasing demand for GLP-1 medications? 5:45

3M ago5:45

5:45

The wildly popular drugs, prescribed for weight loss and type 2 diabetes, are putting a strain on the capabilities of contract development and manufacturing organizations.Greg Slabodkin Read by Brittany Duncan https://www.pharmamanufacturing.com/sector/contract-manufacturing/article/55314756/can-cdmos-keep-up-with-the-increasing-demand-for-glp-1-me…

1
The Play Podcast - 101 - The 101 Greatest Plays 1:17:05

3M ago1:17:05

1:17:05

Episode 101: The 101 Greatest Plays Host: Douglas Schatz Guests: Michael Billington Mark Lawson Welcome to The Play Podcast where we explore the greatest new and classic plays. Each episode we choose a single play to talk about in depth with our expert guest. We'll discuss the play's origins, its themes, characters, structure and impact. For us the…

1
FDA’s program to speed up US manufacturing buildouts is short on detail 5:49

4M ago5:49

5:49

While the agency’s PreCheck regulatory framework is a good first step, it remains to be seen whether the program boosts U.S. drug manufacturing, says former FDA official.Greg Slabodkin Read by Brittany Duncan https://www.pharmamanufacturing.com/all-articles/article/55309136/fdas-program-to-speed-up-us-manufacturing-buildouts-is-short-on-detail…

1
New Jersey remains hot life sciences hub despite macroeconomic, funding headwinds 5:25

4M ago5:25

5:25

The Garden State, called the “medicine chest” to the world, continues to show robust activity with life sciences firms accounting for nearly 30% of all Q2 leasing activity.Greg Slabodkin Read by Brittany Duncan https://www.pharmamanufacturing.com/all-articles/article/55308250/new-jersey-remains-hot-life-sciences-hub-despite-macroeconomic-funding-he…

1
The Play Podcast - 100 - A Moon for the Misbegotten, by Eugene O'Neill 1:15:57

4M ago1:15:57

1:15:57

Episode 100: A Moon for the Misbegotten by Eugene O'Neill Host: Douglas Schatz Guest: Beth Wynstra Welcome to The Play Podcast where we explore the greatest new and classic plays. Each episode we choose a single play to talk about in depth with our expert guest. We'll discuss the play's origins, its themes, characters, structure and impact. For us …

1
The Play Podcast - 099 - Till the Stars Come Down, by Beth Steel 1:07:57

5M ago1:07:57

1:07:57

Episode 099: Till the Stars Come Down by Beth Steel Host: Douglas Schatz Guest: Beth Steel Welcome to The Play Podcast where we explore the greatest new and classic plays. Each episode we choose a single play to talk about in depth with our expert guest. We'll discuss the play's origins, its themes, characters, structure and impact. For us the play…

1
Critical Timing: Hikma’s Billion-Dollar U.S. Investment 6:44

5M ago6:44

6:44

Generics, which make up approximately 90% of prescription volume in the U.S., are produced primarily in India as Hikma looks to onshore production of these critical drugs.Greg Slabodkin Read by Brittany Duncan https://www.pharmamanufacturing.com/all-articles/article/55302441/hikmas-planned-1b-us-investment-comes-at-critical-time-for-generic-medicin…

1
The Play Podcast - 098 - Stereophonic, by David Adjmi 1:09:20

5M ago1:09:20

1:09:20

Episode 098: Stereophonic by David Adjmi Host: Douglas Schatz Guest: David Adjmi Welcome to The Play Podcast where we explore the greatest new and classic plays. Each episode we choose a single play to talk about in depth with our expert guest. We'll discuss the play's origins, its themes, characters, structure and impact. For us the play is the th…

1
Editor’s (re)View: Is the biopharma industry’s glass half empty or half full? 4:47

5M ago4:47

4:47

While macroeconomic uncertainty weighs on the sector, there are glimmers of hope in some areas of pharmaceutical outsourcing and services.Greg Slabodkin Read by Brittany Duncan Read Article Here: https://www.pharmamanufacturing.com/editors-review/article/55299879/editors-review-is-the-biopharma-industrys-glass-half-empty-or-half-full…

1
Life sciences manufacturers overwhelmingly embrace smart tech: global survey 5:00

6M ago5:00

5:00

Smart manufacturing is “nearly universal” with 95% of manufacturers saying they are using or evaluating smart technology, according to a new survey from Rockwell Automation. Greg Slabodkin Read by Brittany DuncanBy Pharma Manufacturing

1
The Play Podcast - 097 - Giant, by Mark Rosenblatt 1:01:03

6M ago1:01:03

1:01:03

Episode 097: Giant by Mark Rosenblatt Host: Douglas Schatz Guest: Mark Rosenblatt Welcome to The Play Podcast where we explore the greatest new and classic plays. Each episode we choose a single play to talk about in depth with our expert guest. We'll discuss the play's origins, its themes, characters, structure and impact. For us the play is the t…

1
Flow state: The evolving shape of continuous manufacturing 15:11

6M ago15:11

15:11

While the pharmaceutical industry has been slow to adopt continuous manufacturing, it appears to be gaining momentum.Greg Slabodkin Read by Brittany Duncan Enjoy the article Here: https://www.pharmamanufacturing.com/all-articles/article/55295669/flow-state-the-evolving-shape-of-continuous-manufacturing…

1
Men in Black - Part 2 49:18

6M ago49:18

49:18

Answering questions from Script Club members attending online, Barry talks about everything from the evolution of the script to working with Will Smith and Tommy Lee Jones and why he doesn’t want his actors to act. Host Luke Foster is also joined by screenwriter and novelist Danny King, screenwriter, script consultant and editor David Wigram, and w…

1
Men in Black - Part 1 46:03

6M ago46:03

46:03

Host Luke Foster is joined by screenwriter and novelist Danny King, screenwriter, script consultant and editor David Wigram, and writer, editor and creative consultant Corey Brotherson. We talked about everything from the way the characters and the story world are introduced to the script’s effective blend of action and comedy. You can read the scr…

1
The Play Podcast - 096 - Dealer's Choice, by Patrick Marber 57:43

7M ago57:43

57:43

Episode 096: Dealer's Choice by Patrick Marber Host: Douglas Schatz Guest: Matthew Dunster Welcome to The Play Podcast where we explore the greatest new and classic plays. Each episode we choose a single play to talk about in depth with our expert guest. We'll discuss the play's origins, its themes, characters, structure and impact. For us the play…

1
[Solutions Spotlight] Hydrogenation: Bridging the gap between nitration and phosgenation 18:15

7M ago18:15

18:15

Hydrogenation can serve as a critical link in chemical synthesis, particularly between nitration and phosgenation. When integrated strategically, it helps enable safer, more efficient production processes. To better understand this connection, we spoke with Dr. Luca Mantilli, R&D Chemist at Valsynthese, the fine chemicals division of Société Suisse…

1
The Play Podcast - 095 - Rhinoceros, by Eugène Ionesco 1:13:08

7M ago1:13:08

1:13:08

Episode 095: Rhinoceros by Eugène Ionesco Host: Douglas Schatz Guest: Omar Elerian Welcome to The Play Podcast where we explore the greatest new and classic plays. Each episode we choose a single play to talk about in depth with our expert guest. We'll discuss the play's origins, its themes, characters, structure and impact. For us the play is the …

1
Editor’s (re)View: BMS, Merck, Roche see manufacturing flexibility as key to dealing with tariffs 4:26

8M ago4:26

4:26

The three Big Pharma companies on their earnings calls this week tried to reassure investors that they have the global footprints to mitigate the effects of tariffs.By Pharma Manufacturing

1
Thermo Fisher opens cell therapy center, FDA cites Aurobindo site, Trump probes pharma imports ahead of tariffs [The good, the bad, the ugly] 4:13

8M ago4:13

4:13

The good — Thermo Fisher opens center to boost cell therapy development The bad — FDA cites Aurobindo plant after Raleigh inspection The ugly — Trump probes pharma imports as tariff threat loomsBy Pharma Manufacturing

1
Novartis to invest $23B in US sites, US urged to invest $15B in biotech counter to China, Trump warns of major pharma tariffs [The good, the bad, the ugly] 4:10

8M ago4:10

4:10

Join us each week as we do a quick review of three compelling stories from the pharma world — one good, one bad, and one ugly. Up this week: The good — Novartis to invest $23B in U.S. manufacturing and R&D, including seven new sites The bad — U.S. urged to invest $15B to counter China’s biotech rise The ugly — Trump signals ‘major’ tariffs on pharm…

1
The Play Podcast - 094 - Oedipus the King, by Sophocles 1:00:30

9M ago1:00:30

1:00:30

Episode 094: Oedipus the King by Sophocles Host: Douglas Schatz Guest: Professor Edith Hall Welcome to The Play Podcast where we explore the greatest new and classic plays. Each episode we choose a single play to talk about in depth with our expert guest. We'll discuss the play's origins, its themes, characters, structure and impact. For us the pla…

1
Cellares, Cabaletta validate automated CAR T production, FDA warns Aspen over sterility issues, rejects Hengrui, Elevar cancer combo again [The good, the bad, the ugly] 3:18

9M ago3:18

3:18

Join us each week as we do a quick review of three compelling stories from the pharma world — one good, one bad, and one ugly. Up this week: The good — Cellares, Cabaletta validate automated CAR T production The bad — FDA warns Aspen over sterility issues The ugly — FDA rejects Hengrui, Elevar cancer combo again…

1
Axplora expands ADC capacity, Merck KGaA CDMO business slump, FDA issues a warning letter to Granules India [The good, the bad, the ugly] 3:44

9M ago3:44

3:44

Join us each week as we do a quick review of three compelling stories from the pharma world — one good, one bad, and one ugly. Up this week: The good — Axplora expands its antibody-drug conjugate (ADC) manufacturing capacity to support growing demand. The bad — Merck KGaA’s CDMO business reports a decline The ugly — The FDA issues a warning letter …

1
The Play Podcast - 093 - Three Sisters, by Anton Chekhov 1:09:01

9M ago1:09:01

1:09:01

Episode 093: Three Sisters by Anton Chekhov Host: Douglas Schatz Guest: Rory Mullarkey Welcome to The Play Podcast where we explore the greatest new and classic plays. Each episode we choose a single play to talk about in depth with our expert guest. We'll discuss the play's origins, its themes, characters, structure and impact. For us the play is …

1
Eli Lilly expands manufacturing to boost supply, FDA blocks imports from two Indian API makers, ICU Medical recalls potassium chloride injection bags over labeling error [The good, the bad, the ugly] 3:54

10M ago3:54

3:54

Join us each week as we do a quick review of three compelling stories from the pharma world — one good, one bad, and one ugly. Up this week: The good — Eli Lilly expands manufacturing to boost supply The bad — FDA blocks imports from two Indian API makers over manufacturing violations The ugly — ICU Medical recalls potassium chloride injection bags…

1
Women Talking 47:26

10M ago47:26

47:26

Episode Four: Women Talking Join us for an in-depth discussion about Sarah Polley’s script for Women Talking. Host Luke Foster is joined by screenwriter, producer and author Scott Myers, filmmaker, editor and producer Deborah Espect, and film director Abbie Lucas. Writer/Director Nathan Haines fields questions and comments from Script Club members …

1
Novartis boosts Slovenia investment to $3.6B, Trump tariffs could unsettle biopharma FDI, FDA warns Global Calcium, blocks US imports [The good, the bad, the ugly] 4:24

10M ago4:24

4:24

Join us each week as we do a quick review of three compelling stories from the pharma world — one good, one bad and one ugly. Up this week: The good — Novartis boosts Slovenia investment to $3.6B The bad — Trump tariffs unsettle biopharma FDI The ugly — FDA warns Global Calcium, blocks US importsBy Pharma Manufacturing

1
The Play Podcast - 092 - A Raisin in the Sun, by Lorraine Hansberry 1:03:06

10M ago1:03:06

1:03:06

Episode 092: A Raisin in the Sun by Lorainne Hansberry Host: Douglas Schatz Guest: Tinuke Craig Welcome to The Play Podcast where we explore the greatest new and classic plays. Each episode we choose a single play to talk about in depth with our expert guest. We'll discuss the play's origins, its themes, characters, structure and impact. For us the…

1
The Play Podcast - 091 - Cat on a Hot Tin Roof, by Tennessee Williams 56:28

11M ago56:28

56:28

Episode 091: Cat on a Hot Tin Roof by Tennessee Williams Host: Douglas Schatz Guest: Arifa Akbar Welcome to The Play Podcast where we explore the greatest new and classic plays. Each episode we choose a single play to talk about in depth with our expert guest. We'll discuss the play's origins, its themes, characters, structure and impact. For us th…

1
In Bruges 54:04

11M ago54:04

54:04

Episode Three: In Bruges Join us for an in-depth discussion about Martin McDonagh's screenplay for In Bruges. Host Luke Foster is joined by screenwriter and story consultant Ian Long and Dutch screenwriter Liz van Ingen. Writer/Director Nathan Haines fields questions and comments from Script Club members attending live online. We talked about every…

1
Fleabag 49:43

11M ago49:43

49:43

Episode Two: Fleabag Join us for an in-depth discussion about Phoebe Waller-Bridge's script for Series Two, Episode One of Fleabag. Host Luke Foster is joined by Brazilian screenwriter, filmmaker and author Alessandra De Blasi, screenwriter Lorna Riley and long-time BBC1 screenwriter Tina Walker. Writer/Director Nathan Haines fields questions and c…

1
Everything Everywhere All At Once 49:12

11M ago49:12

49:12

Episode One: Everything Everywhere All At Once Join us for an in-depth discussion about Daniel Kwan and Daniel Scheinert's Oscar-winning screenplay for Everything Everywhere All At Once. Host Luke Foster is joined by writer, actor and improviser Vera Chok, writer, director and 2021 Sundance nominee Nomawonga Khumalo and screenwriter and script cons…

1
FDA approves Opdivo subcutaneous version, Marinus Pharmaceuticals sells operations, Novo Nordisk pushes back against compounding pharmacies [The good, the bad, the ugly] 3:19

11M ago3:19

3:19

Join us each week as we do a quick review of three compelling stories from the pharma world — one good, one bad and one ugly. Up this week: The good — FDA approves Opdivo subcutaneous version The bad — Marinus Pharmaceuticals sells operations The ugly — Novo Nordisk pushes back against compounding pharmacies…

1
The Play Podcast - 090 - The Importance of Being Earnest, by Oscar Wilde 56:52

11M ago56:52

56:52

Episode 090: The Importance of Being Earnest by Oscar Wilde Host: Douglas Schatz Guest: Max Webster Welcome to The Play Podcast where we explore the greatest new and classic plays. Each episode we choose a single play to talk about in depth with our expert guest. We'll discuss the play's origins, its themes, characters, structure and impact. For us…

1
The Play Podcast - 089 - Waiting for Godot, by Samuel Beckett 56:23

12M ago56:23

56:23

Episode 089: Waiting for Godot by Samuel Beckett Host: Douglas Schatz Guest: Matthew McFrederick Welcome to The Play Podcast where we explore the greatest new and classic plays. Each episode we choose a single play to talk about in depth with our expert guest. We'll discuss the play's origins, its themes, characters, structure and impact. For us th…

1
EU approves Novo-Catalent acquisition, CDMO National Resilience announces layoffs, FDA investigates blood cancer reports in gene therapy patients [The good, the bad, the ugly] 2:58

12M ago2:58

2:58

Join us each week as we do a quick review of three compelling stories from the pharma world — one good, one bad and one ugly. Up this week: The good — EU approves Novo-Catalent acquisition The bad — CDMO National Resilience announces layoffs The ugly — FDA investigates blood cancer reports in gene therapy patients…